间隙结β-4通过MET-AKT激活在胰腺癌中加速细胞周期进展和转移
Joji Muramatsu1, Yohei Arihara1, Makoto Yoshida1
1Department of Medical Oncology, Sapporo Medical University School of Medicine, Sapporo, Japan.
Cancer science
|February 11, 2024
概括
胰腺癌显示高隙结β-4 (GJB4) 蛋白,对生存有负面影响. 针对GJB4-MET途径为这种预后不佳的癌症提供了潜在的新疗法策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 尽管治疗方面取得了进展,但胰腺癌的预后仍然令人丧.
- 差距连接蛋白正在成为癌症中潜在的治疗点.
- 缺口结β-4 (GJB4) 在胰腺癌中的特定作用目前尚不清楚.
研究的目的:
- 研究GJB4在胰腺癌中的作用和预后意义.
- 在胰腺癌模型中探索向GJB4的治疗潜力.
主要方法:
- 胰腺癌组织与正常组织中的GJB4转录水平的生物信息分析.
- 评估GJB4表达作为预后因素.
- 在体外研究涉及GJB4在胰腺癌细胞系中被淘汰和过度表达.
- 使用老鼠异种移植模型进行体内研究.
- 对GJB4-MET-AKT信号通路的研究.
主要成果:
- 胰腺癌组织的GJB4转录水平高于正常组织,与整体存活率降低相关.
- 高核GJB4表达是一个负的预后指标.
- GJB4的敲除会诱导G0/G1细胞循环停止,减少增殖,并抑制转移.
- 过度表达GJB4增强了扩散,迁移和入侵,其影响被MET抑制逆转.
- 抑制GJB4在体内抑制瘤生长,并降低MET-AKT信号的调节.
结论:
- 增加GJB4表达是胰腺癌的显著负面预后因素.
- GJB4-MET轴在胰腺癌的进展中起着至关重要的作用.
- 针对GJB4-MET轴是一个有前途的胰腺癌治疗策略.
更多相关视频
07:29Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
19.6K
10:32Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
Published on: December 19, 2019
10.9K
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
MAPK Signaling Cascades
5.5K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
